Introduction
Screening individuals at risk for Alzheimer's disease (AD) based on medical health records in 7 5 preclinical stages may lead to more widespread early detection of AD pathology and ultimately 7 6 to better therapeutic strategies for delaying the onset of AD.
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In contrast to biomarkers diabetes, schizophrenia, etc) or mortality. [9] [10] [11] [12] Given the recent rapid growth of the machine 9 9
learning technology, application of the AI technology to clinical predictive modeling is likely to 1 0 0 have a deep impact on medicine. [13] [14] [15] But to our knowledge data-driven predictive modeling with 1 0 1 EHR data has not been previously used to predict incident AD. bias an improving generalizability. In the present study, we use a large nationally representative database. 16 We construct and validate data-driven machine learning models to predict future 1 0 9
incidence of AD using the extensive measures collected within the EHR. We demonstrate the 1 1 0 feasibility of developing accurate prediction models for AD which may then provide a starting 1 1 1 point for future. representative of the Korean population because for the years investigated in this study, the 1 2 7
Korean NHIS covered over 96% of the entire 50-million South Korean population; thus, presents Of those samples, 40,736 elders were selected in this study, whose records exist in all the three available data) (IRB number NHIMC 2018-12-006). Incident AD was the outcome variable. We used the two criteria to define AD: ICD-10 codes of 1 4 0 AD 1 8 (F00, F00.0, F00.1, F00.2, F00.9, G30, G30.0, G30.1, G30.8, G30.9) and dementia 1 4 1 medication prescribed with an initial AD diagnosis (e.g., donepezil, rivastigmine, galantamine, 1 4 2 and memantine). When both criteria were used, we labeled it as definite AD. We also 1 4 3 considered a broader definition of AD using only ICD-10 codes to minimize false negative cases 1 4 4 (e.g. individuals with AD diagnose who did not take medication); this was labeled as probable 1 4 5
AD. Within each individual with AD incidence, the EHR after the AD incidence was excluded. We conducted predictive modeling using both outcome variables. We used the following variables from the EHR data: 21 features including laboratory values, Our data preprocessing steps are as follows. (i) EHR alignment: We aligned the EHRs to each 1 5 7
individual's initial AD diagnosis (event-centric ordering). (ii) ICD-10 and medication coding:
Since ICD-10 and medication codes have hierarchical structures, we used the first disease Alzheimer´s disease, unspecified]), and the first 4 characters for the medication codes in the entire data were excluded from the analysis (1,179 disease and 362 medication codes). years of the processed data (in Korea an biannual health screening is required for every elder),
we excluded that participant from the analysis. This preprocessing procedure yielded 4,894
unique variables used in the models (see Table 3 for detailed information). We implemented three machine learning algorithms: random forest, support vector machine 1 7 9
with linear kernel, and logistic regression. Model training, validation, and testing was done using 1 8 0 nested stratified 5-fold cross validation with 5 iterations. Feature selection was done within train 1 8 1 sets using the variance threshold method.
1 9
Hyper-parameters optimization was done within 1 8 2 validation sets. The following parameters were tuned: for random forest, the minimum number assessed on the test sets. We measured the following model performance metrics in the test set:
The area under the receiver operating characteristic curve (ROC), sensitivity and specificity. We Classifiers were trained on these to predict 0,1,2,3, and 4 subsequent-year incidence of AD. Numbers of features and look-back periods also decreased in later year ( Table 3) . This study assessed the utility of the EHR in predicting the future incidence of AD. Using 2 2 1 machine learning, we predicted future incidence of AD with acceptable accuracy in terms of AD screening, when combined with rigorous data-driven machine learning. when to seek a further clinical assessment to a given patient in an individual-specific manner. hemoglobin level was selected as the feature most strongly associated with incident AD. Indeed, 2 4 2 anemia is known as an important risk factor for dementia. [21] [22] [23] A study using National Health shows the hemoglobin level as the most significant predictor. This finding has implications for 2 4 7 public health because anemia is a modifiable factor. Given our finding and the consistent We also noted a positive association between urine protein level and incident AD. In the EHR, 2 5 3 protein in urine is typically measured using urine dip stick. This approach is not a quantitative 2 5 4 measure of urine protein, but it is useful as a screening method for proteinuria. 25, 26 Literature 2 5 5
shows association between albuminuria and dementia. 27 Our finding suggests the potential 1 5
Zotepine is an atypical antipsychotic drug with proven efficacy for treatment of schizophrenia.
2 7 0
Our model showed the use of zotepine positively correlated with incident AD. There are two 2 7 1 possible interpretations. Some studies indicate that individuals with schizophrenia may have an 2 7 2 increased risk for the development of dementia. 32 It is possible that the incident AD was high in psychological symptoms of dementia (BPSD) were not detected. Nicametate Citrate, a vasodilator, was also negatively associated with incident AD. This may be reducing the risk of vascular dementia, although the exact mechanism remains unclear. Further research is required. One of the limitations of this study is that diagnose of AD in our EHR is not clinically ascertained.
Dementia Rating) = 1~3 or GDS (Global Deterioration Scale)= 3~7; for galantamine and Figure 2) . Thus, it is highly likely that individuals with records of receiving 3 0 4 dementia medication meet strong diagnostic criteria. Another limitation of this study is that generalizability of our findings to ethnicities other than 3 0 7
Asian or to different healthcare systems remains to be tested. In sum, this study presents the first data in predicting future incident AD using data-driven 
